Sanai, Faisal M <br/><br/>
Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis.  [electronic resource] 

 -  The Journal of infection  06 2018 
 - 536-542 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1532-2742 
<br/><br/><label>Standard No.: </label>10.1016/j.jinf.2018.04.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Cohort Studies<br/>Female<br/>Fluorenes--administration & dosage<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Liver Cirrhosis--drug therapy<br/>Male<br/>Middle Aged<br/>Ribavirin--administration & dosage<br/>Sofosbuvir<br/>Sustained Virologic Response<br/>Treatment Outcome<br/>Uridine Monophosphate--administration & dosage